[arbee4bush]

In a breakthrough development, the Israeli company Vaxil BioTherapeutics has formulated a therapeutic cancer vaccine, now in clinical trials at Hadassah University Medical Center in Jerusalem. If all goes well, the vaccine could be available about six years down the road, to administer on a regular basis not only to help treat cancer but in order to keep the disease from recurring.

The vaccine is being tested against a type of blood cancer called multiple myeloma. If the substance works as hoped — and it looks like all arrows are pointing that way — its platform technology VaxHit could be applied to 90 percent of all known cancers, including prostate and breast cancer, solid and non-solid tumors.

A vaccine that works like a drug

A traditional vaccine helps the body’s immune system fend off foreign invaders such as bacteria or viruses, and is administered to people who have not yet had the ailment. Therapeutic vaccines, like the one Vaxil has developed, are given to sick people, and work more like a drug.

[Eye of Unk]

It would indeed be some outstanding news, but I bet Americans won’t see it for a long long time, and if they doo it will be way out of range pricewise, only the rich can buy it.

I hope Israel offers it at an almost giveaway price to anyone, let them take the stage while the Moslems still will try to destroy them.

It may be political timing for support but what the heck if it works all the more power for Israel, they truly need support.

[Iron Munro]

Better get copies of the research documents out of the country before Obama unleashes more of his Arab Spring on the Israelis.

[Rumplemeyer]

bump

[DocRock]

Bookmark

[Hemingway's Ghost]

Good/hopeful news ping.